Perspectives on Neuroscience and Behavior.

IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY Neuroscientist Pub Date : 2023-04-01 DOI:10.1177/10738584231157277
{"title":"Perspectives on Neuroscience and Behavior.","authors":"","doi":"10.1177/10738584231157277","DOIUrl":null,"url":null,"abstract":"There is an overlap in genetics, risk factors, symptomatology, and some biologic measures among major depressive disorder, bipolar disorder, and schizophrenia spectrum disorder. Now, a reduction in gray matter volume (GMV) has been found in the left hippocampus in all three disorders. GMV was obtained by utilizing a 3-T MRI scanner in 110 individuals in each of 4 groups matched for age and sex that consisted of healthy controls and DSM-IV-TR–diagnosed major depressive disorder, bipolar disorder, and schizophrenia spectrum disorder. Left hippocampus GMV was not only reduced in the 3 patient groups but associated with current global assessment of functioning and neuropsychological measurement of working memory/executive functioning. Stressful life events experienced during the last 6 months were also associated with left hippocampus GMV in the 3 patient groups and, importantly, also in the controls. Although a specific causal abnormality has been found in many diseases, the pathophysiology can involve multiple factors that overlap diseases at the biologic and symptomatic levels (e.g., inflammation, fever, fatigue). Numerous studies have shown that the hippocampus is highly sensitive to the effects of stress, and this suggests that the reduced GMV seen across the 3 patient groups is at least in part due to stress. Since there are available pharmacologic and behavioral measures to reduce stress, these can be utilized to reduce the effects of stress in major psychiatric disorders.","PeriodicalId":49753,"journal":{"name":"Neuroscientist","volume":"29 2","pages":"149"},"PeriodicalIF":3.5000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscientist","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10738584231157277","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There is an overlap in genetics, risk factors, symptomatology, and some biologic measures among major depressive disorder, bipolar disorder, and schizophrenia spectrum disorder. Now, a reduction in gray matter volume (GMV) has been found in the left hippocampus in all three disorders. GMV was obtained by utilizing a 3-T MRI scanner in 110 individuals in each of 4 groups matched for age and sex that consisted of healthy controls and DSM-IV-TR–diagnosed major depressive disorder, bipolar disorder, and schizophrenia spectrum disorder. Left hippocampus GMV was not only reduced in the 3 patient groups but associated with current global assessment of functioning and neuropsychological measurement of working memory/executive functioning. Stressful life events experienced during the last 6 months were also associated with left hippocampus GMV in the 3 patient groups and, importantly, also in the controls. Although a specific causal abnormality has been found in many diseases, the pathophysiology can involve multiple factors that overlap diseases at the biologic and symptomatic levels (e.g., inflammation, fever, fatigue). Numerous studies have shown that the hippocampus is highly sensitive to the effects of stress, and this suggests that the reduced GMV seen across the 3 patient groups is at least in part due to stress. Since there are available pharmacologic and behavioral measures to reduce stress, these can be utilized to reduce the effects of stress in major psychiatric disorders.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
神经科学与行为透视。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neuroscientist
Neuroscientist 医学-临床神经学
CiteScore
11.50
自引率
0.00%
发文量
68
期刊介绍: Edited by Stephen G. Waxman, The Neuroscientist (NRO) reviews and evaluates the noteworthy advances and key trends in molecular, cellular, developmental, behavioral systems, and cognitive neuroscience in a unique disease-relevant format. Aimed at basic neuroscientists, neurologists, neurosurgeons, and psychiatrists in research, academic, and clinical settings, The Neuroscientist reviews and updates the most important new and emerging basic and clinical neuroscience research.
期刊最新文献
A new frontier in the treatment of schizophrenia. Forthcoming Articles. Single-Nuclei Multiomics of the Prefrontal Cortex: 388 Brains Tell a Powerful Story. The Day After. Activity-Dependent Synapse Refinement: From Mechanisms to Molecules.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1